Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539800 of 542236 entries
View as:

SBIR/ STTR Family Check-up Online

Phase: N/A Priority: Normal
NCT ID: NCT06876246 Org: User:
Start: 01/20/25 End: 08/31/27 Due: 08/31/28

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01144455 Org: User:
Start: 06/30/10 End: 12/31/14 Due: 12/31/15

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06842472 Org: User:
Start: 02/28/25 End: 12/31/29 Due: 12/31/30

Hypofractionated Radiosurgery to Treat Residual/recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

Phase: N/A Priority: Normal
NCT ID: NCT06826170 Org: User:
Start: 09/14/20 End: 02/29/28 Due: 02/28/29

Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06858423 Org: User:
Start: 08/15/23 End: 05/31/24 Due: 05/31/25

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Phase: N/A Priority: Normal
NCT ID: NCT06659445 Org: User:
Start: 03/31/25 End: 11/30/27 Due: 11/30/28

Behavioral Indicators of Pain Representation

Phase: N/A Priority: Normal
NCT ID: NCT06669767 Org: User:
Start: 11/14/24 End: 09/30/25 Due: 09/30/26

Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03325751 Org: User:
Start: 06/01/18 End: 11/01/19 Due: 11/01/20

Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters

Phase: N/A Priority: Normal
NCT ID: NCT02854475 Org: User:
Start: 07/31/16 End: 07/31/16 Due: 07/31/17

An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

Phase: N/A Priority: Normal
NCT ID: NCT00210860 Org: User:
Start: 09/30/04 End: 03/31/06 Due: 03/31/07

Trajectories of Quality of Life by the Elderly in Early Phase of Dementia

Phase: N/A Priority: Normal
NCT ID: NCT02845830 Org: User:
Start: 09/30/16 End: 07/31/20 Due: 07/31/21

Study of Emu Oil vs. Placebo for Vulvar Pain in Women.

Phase: N/A Priority: Normal
NCT ID: NCT01295268 Org: User:
Start: 02/28/11 End: 08/31/11 Due: 08/31/12

Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia

Phase: N/A Priority: Normal
NCT ID: NCT03784365 Org: User:
Start: 12/01/18 End: 03/31/20 Due: 03/31/21

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02652767 Org: User:
Start: 02/23/16 End: 07/04/19 Due: 07/04/20

Effect of Cannula Size on Oxygen Saturation During Nasal High Flow Therapy in Newborns

Phase: N/A Priority: Normal
NCT ID: NCT04459429 Org: User:
Start: 06/26/20 End: 12/24/20 Due: 12/24/21

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05546853 Org: User:
Start: 03/28/23 End: 06/16/25 Due: 06/16/26

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05672199 Org: User:
Start: 04/28/23 End: 10/31/24 Due: 10/31/25

School Oral Health Intervention in Nepal

Phase: N/A Priority: Normal
NCT ID: NCT05811650 Org: User:
Start: 02/10/20 End: 03/31/22 Due: 03/31/23

A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Phase: N/A Priority: Normal
NCT ID: NCT05893797 Org: User:
Start: 10/05/23 End: 09/16/24 Due: 09/16/25

Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

Phase: N/A Priority: Normal
NCT ID: NCT05064839 Org: User:
Start: 10/06/21 End: 08/18/23 Due: 08/18/24

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01115803 Org: User:
Start: 03/31/10 End: 06/30/11 Due: 06/30/12

Study on Susceptibility Genes and Pathogenic Mechanism of Non-syndromic Familial Aortic Dissection

Phase: N/A Priority: Normal
NCT ID: NCT04439565 Org: User:
Start: 06/17/20 End: 07/17/23 Due: 07/17/24

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT01569464 Org: User:
Start: 03/31/12 End: 04/30/13 Due: 04/30/14

Peri-implantitis in HIV-positive Patients With Different Dental Prosthesis

Phase: N/A Priority: Normal
NCT ID: NCT04983212 Org: User:
Start: 03/20/20 End: 07/20/20 Due: 07/20/21

The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT01025765 Org: User:
Start: 11/30/09 End: 12/31/12 Due: 12/31/13